We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current AOXG market cap is 2.39M. The company's latest EPS is USD 0.0000 and P/E is N/A.
| Year End June 29 2024 | 2014 | 2015 | 2016 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 12.74M | 25.48M | 32.33M | 0 | 0 |
| Operating Income | -3.44M | 8.6M | 6.14M | 0 | -15k |
| Net Income | -8.22M | 5.5M | 2.06M | 0 | -15k |
| Year End June 29 2024 | 2014 | 2015 | 2016 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 38.08M | 53.04M | 56.23M | 0 | 0 |
| Total Liabilities | 42.08M | 42.98M | 38.16M | 0 | 61k |
| Total Equity | -4.01M | 10.06M | 18.08M | 0 | -61k |
| Year End June 29 2024 | 2014 | 2015 | 2016 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.73M | 3.06M | -535k | N/A | N/A |
| Investing | -269k | -2.71M | -118k | N/A | N/A |
| Financing | 6.31M | 2.67M | 2.95M | N/A | N/A |
| Market Cap | 2.39M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | -55.94 |
| Dividend Yield | - |
| Shares Outstanding | 341.21M |
| Average Volume (1 week) | 1.65k |
| Average Volume (1 Month) | 60.14k |
| 52 Week Change | 52.17% |
| 52 Week High | 0.0178 |
| 52 Week Low | 0.0018 |
| Spread (Intraday) | 0 (38%) |
| Company Name | Aoxing Pharmaceutical Company Inc (PK) |
| Address |
1098 foster city blvd., suite 106-810 foster city, california 94404 |
| Website | https://www.aoxingpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
